Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5133847 | 0.98 | CTSK (0.51) | CTSKCTSS | |
| SCHEMBL628885 | 0.95 | CTSK (0.57) | CTSKCTSS | |
| SCHEMBL1843190 | 0.87 | CTSK (0.53) | CTSKCTSS | |
| SCHEMBL1251053 | 0.86 | TDP1 (0.53) | CTSKCTSS | |
| SCHEMBL31121751 | 0.84 | CTSK (0.54) | CTSKCTSS | |
| SCHEMBL31121749 | 0.84 | CTSK (0.54) | CTSKCTSS | |
| SCHEMBL7804302 | 0.84 | TDP1 (0.50) | CTSKCTSS | |
| SCHEMBL880670 | 0.83 | MEN1 (0.59) | CTSKCTSS | |
| SCHEMBL15015920 | 0.83 | MEN1 (0.44) | CTSKCTSS | |
| SCHEMBL24465592 | 0.83 | CTSK (0.56) | CTSKCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8512971-B2 | Compounds and methods of use thereof for assaying lysophospholipase D activity | ECHELON BIOSCIENCES, INC. (US) | 2013-08-20 | — | — | US | disclosed |
| US-7989663-B2 | Compounds and methods of use thereof for assaying lysophospholipase D activity | ECHELON BIOSCIENCES INCORPORATED (US) | 2011-08-02 | — | — | US | disclosed |
| US-20100260682-A1 | Compounds and methods of use thereof for assaying lysophospholipase D activity | ECHELON BIOSCIENCES INCORPORATED (US) | 2010-10-14 | — | — | US | disclosed |
| CN-101801429-A | The immobilization on medical treatment device of dyestuff and antimicrobial | BAXTER INT | 2010-08-11 | — | — | CN | disclosed |
| US-20090068697-A1 | Compounds and methods of use thereof for assaying lysophospholipase D activity | ECHELON BIOSCIENCES INCORPORATED (US) | 2009-03-12 | — | — | US | disclosed |
| US-20090024096-A1 | IMMOBILIZATION OF DYES AND ANTIMICROBIAL AGENTS ON A MEDICAL DEVICE | BAXTER INTERNATIONAL INC. (US) | 2009-01-22 | — | — | US | disclosed |
| US-7459285-B2 | Compounds and methods of use thereof for assaying lysophospholipase D activity | ECHELON BIOSCIENCES INCORPORATED (US) | 2008-12-02 | — | — | US | disclosed |
| US-7388112-B2 | Immunomodulation with novel pharmaceutical compositions | MEDIQUEST THERAPEUTICS, INC. (US) | 2008-06-17 | — | — | US | disclosed |
| US-20060167054-A1 | Immunomodulation with novel pharmaceutical compositions | MEDIQUEST THERAPEUTICS, INC. (US) | 2006-07-27 | — | — | US | disclosed |
| US-6919483-B2 | Immunomodulation with novel pharmaceutical compositions | MEDIQUEST THERAPEUTICS, INC. (US) | 2005-07-19 | — | — | US | disclosed |
| US-20040235960-A1 | Immunomodulation with novel pharmaceutical compositions | MEDIQUIST THERAPRUTICS, INC. | 2004-11-25 | — | — | US | disclosed |
| US-20040171096-A1 | Compounds and methods of use thereof for assaying lysophospholipase D activity | ECHELON BIOSCIENCES INCORPORATED | 2004-09-02 | — | — | US | disclosed |
| WO-2004053459-A2 | COMPOUNDS AND MEHTODS OF USE THEREOF FOR ASSAYING LYSOPHOSPHOLIPASE D ACTIVITY | ECHELON BIOSCIENCES INCORPORATED (US) | 2004-06-24 | — | — | WO | disclosed |
| EP-0556216-B1 | PHOSPHORIC ACID ESTERS AND THEIR USE IN THE PREPARATION OF BIOCOMPATIBLE SURFACES | BIOCOMPATIBLES LTD (GB) | 1997-06-04 | — | — | EP | disclosed |
| US-5599587-A | Phosphoric acid esters and their use in the preparation of biocompatible surfaces | BIOCOMPATIBLES LIMITED (GB) | 1997-02-04 | — | — | US | disclosed |
| EP-0556216-A1 | PHOSPHORIC ACID ESTERS AND THEIR USE IN THE PREPARATION OF BIOCOMPATIBLE SURFACES. | BIOCOMPATIBLES LTD (GB) | 1993-08-25 | — | — | EP | disclosed |
| WO-1992007858-A1 | PHOSPHORIC ACID ESTERS AND THEIR USE IN THE PREPARATION OF BIOCOMPATIBLE SURFACES | BIOCOMPATIBLES LIMITED (GB) | 1992-05-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090024096-A1 | IMMOBILIZATION OF DYES AND ANTIMICROBIAL AGENTS ON A MEDICAL DEVICE | CD99, CD44, ACR | CTSK 1215/4885CTSS 449/4885 |
| US-20090068697-A1 | Compounds and methods of use thereof for assaying lysophospholipase D activity | LYPLAL1, LPCAT3, LPCAT1 | CTSK 240/4885CTSS 201/4885 |
| US-20100260682-A1 | Compounds and methods of use thereof for assaying lysophospholipase D activity | LYPLAL1, LPCAT3, LPCAT1 | CTSK 240/4885CTSS 201/4885 |
| US-20040235960-A1 | Immunomodulation with novel pharmaceutical compositions | TNF, IL2, CD40 | CTSK 2476/4885CTSS 1769/4885 |
| US-20060167054-A1 | Immunomodulation with novel pharmaceutical compositions | TNF, IL2, CD40 | CTSK 2639/4885CTSS 1336/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.